Anthropic’s Claude AI autonomously identified a new enzyme system resembling CRISPR, demonstrating AI’s potential to accelerate biological discovery.

Anthropic’s Claude AI has autonomously uncovered a previously unknown enzyme system that mirrors the repeat‑spacer architecture of CRISPR, marking a milestone for artificial intelligence in the field of molecular biology.

Discovery Overview

Claude analyzed millions of genomic sequences from diverse microbial datasets, flagging a recurring pattern of short DNA repeats interspersed with spacer regions that encode a set of associated proteins. The system, now termed CRISPR‑like Enzyme System (CLES), appears to function in adaptive immunity similar to classic CRISPR‑Cas mechanisms.

Key Features of the Enzyme System

  • Short, palindromic repeat sequences flanking variable spacers
  • A conserved nuclease domain resembling Cas12
  • Accessory helicase and methyltransferase proteins
  • Evidence of RNA‑guided target cleavage

Preliminary biochemical assays demonstrated that the CLES complex can bind guide RNAs derived from the spacer regions and cleave complementary DNA substrates in vitro, suggesting a functional parallel to established CRISPR effectors.

Implications for Research and Biotechnology

The AI‑driven discovery showcases how large language models can sift through vast genomic repositories faster than traditional manual curation, potentially accelerating the identification of novel biotechnological tools. If further validated, CLES could expand the repertoire of programmable nucleases for genome editing, diagnostics, and synthetic biology.

Anthropic plans to release the full dataset and computational pipeline used by Claude, inviting the scientific community to replicate and extend the findings.

Anthropic announcement of Claude’s discovery of a novel enzyme system